APA (7th ed.) Citation

GP, S., ME, A., SP, R., R, T., D, K., I, D., . . . A, Z. (2019). CRISPR/Cas9 Editing of Glia Maturation Factor Regulates Mitochondrial Dynamics by Attenuation of the NRF2/HO-1 Dependent Ferritin Activation in Glial Cells. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 14(4), 537. https://doi.org/10.1007/s11481-019-09833-6

Chicago Style (17th ed.) Citation

GP, Selvakumar, et al. "CRISPR/Cas9 Editing of Glia Maturation Factor Regulates Mitochondrial Dynamics by Attenuation of the NRF2/HO-1 Dependent Ferritin Activation in Glial Cells." Journal of Neuroimmune Pharmacology : The Official Journal of the Society on NeuroImmune Pharmacology 14, no. 4 (2019): 537. https://doi.org/10.1007/s11481-019-09833-6.

MLA (9th ed.) Citation

GP, Selvakumar, et al. "CRISPR/Cas9 Editing of Glia Maturation Factor Regulates Mitochondrial Dynamics by Attenuation of the NRF2/HO-1 Dependent Ferritin Activation in Glial Cells." Journal of Neuroimmune Pharmacology : The Official Journal of the Society on NeuroImmune Pharmacology, vol. 14, no. 4, 2019, p. 537, https://doi.org/10.1007/s11481-019-09833-6.